{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-109825","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2024-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.850138+00:00","generated_at":"2026-05-29T02:15:41.777194+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Oramed recieves $13.2M from Scilex, slashing Tranche A principal to $7.7M","bullets":["Scilex paid ~$13.2M on Dec 13, 2024, satisfying the $15M installment due Dec 21.","Combined with prior payments, $94.2M of original $101.9M Tranche A Note has been repaid or refinanced.","Remaining Scilex debt to Oramed: $7.675M (Tranche A) and $25M (Tranche B Notes).","Payment stems from September 2023 securities purchase agreement and subsequent October 2024 refinancing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-109825","json":"https://secwatch.observer/filing/0001213900-24-109825.json","markdown":"https://secwatch.observer/filing/0001213900-24-109825.md","text":"https://secwatch.observer/filing/0001213900-24-109825.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024109825/0001213900-24-109825-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390024109825/ea0225149-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:15:41.777194+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}